PFM Health Sciences’s Cardiovascular Systems, Inc. CSII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-274,689
Closed -$13.3M 83
2019
Q4
$13.3M Sell
274,689
-190,356
-41% -$8.67M 0.64% 42
2019
Q3
$22.1M Buy
465,045
+39,730
+9% +$1.87M 0.65% 46
2019
Q2
$18.3M Sell
425,315
-21,606
-5% -$839K 0.35% 67
2019
Q1
$17.3M Sell
446,921
-1,152,946
-72% -$39.1M 0.38% 67
2018
Q4
$45.6M Buy
1,599,867
+581,950
+57% +$18.5M 1.21% 34
2018
Q3
$39.8M Sell
1,017,917
-213,004
-17% -$7.87M 0.58% 63
2018
Q2
$39.8M Buy
1,230,921
+409,767
+50% +$11.3M 0.62% 64
2018
Q1
$18M Buy
821,154
+271,497
+49% +$6.53M 0.37% 74
2017
Q4
$13M Buy
549,657
+103,766
+23% +$2.62M 0.31% 71
2017
Q3
$12.6M Buy
445,891
+104,675
+31% +$3.18M 0.25% 78
2017
Q2
$11M Sell
341,216
-100,445
-23% -$3.06M 0.3% 75
2017
Q1
$12.5M Buy
441,661
+8,721
+2% +$232K 0.31% 80
2016
Q4
$10.5M Sell
432,940
-69,105
-14% -$1.7M 0.3% 75
2016
Q3
$11.9M Buy
+502,045
New +$11M 0.35% 68

Other funds holding CSII

PFM Health Sciences's CSII Position: Q1 2020 in Review

PFM Health Sciences sold out of Cardiovascular Systems, Inc. (CSII) in Q1 2020, closing a stake of 274,689 shares — an estimated $13.3M sold.

PFM Health Sciences first reported a position in CSII in Q3 2016 and held it in 14 quarters. The position peaked at $45.6M in Q4 2018. 183 funds tracked by Wall St. Rank hold CSII as of Q1 2020.

  • PFM Health Sciences reported no remaining Cardiovascular Systems, Inc. position as of Q1 2020 after selling out during the quarter.
  • PFM Health Sciences sold 274,689 Cardiovascular Systems, Inc. shares in Q1 2020, an estimated $13.3M.
  • PFM Health Sciences first reported a position in Cardiovascular Systems, Inc. in Q3 2016 and held it in 14 quarters.
  • PFM Health Sciences's Cardiovascular Systems, Inc. position peaked at $45.6M in Q4 2018.
  • 183 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q1 2020.

Based on PFM Health Sciences's 13F filing for Q1 2020, filed 15 May 2020.